Aspen Aerogels (ASPN) EBIT (2013 - 2026)

Aspen Aerogels has reported EBIT for 14 years, with the latest figure at -$20.8 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 93.04% year-over-year to -$20.8 million; the trailing twelve-month figure through Mar 2026 stood at $197.2 million (up 179.76% YoY), and the FY2025 full-year result was -$81.3 million, down 249.08% from the prior year.
• EBIT for Q1 2026 stood at -$20.8 million, down from $226.5 million in the prior quarter.
• The five-year high for EBIT was $226.5 million in Q4 2025, with the low at -$299.3 million in Q1 2025.
• Historically, EBIT has averaged -$10.4 million across 5 years, with a median of -$9.7 million in 2022.
• The largest YoY upside for EBIT was 1439.73% in 2025 against a maximum downside of 12388.22% in 2025.
• Aspen Aerogels' EBIT stood at -$9.7 million in 2022, then jumped by 114.31% to $1.4 million in 2023, then surged by 963.85% to $14.7 million in 2024, then jumped by 1439.73% to $226.5 million in 2025, then plunged by 109.2% to -$20.8 million in 2026.
• The last three EBIT figures came in at -$20.8 million (Q1 2026), $226.5 million (Q4 2025), and -$3.3 million (Q3 2025), per Business Quant data.